Abstract:Background: Evidence-based treatment decisions in medicine are made founded on population-level evidence obtained during randomized clinical trials. In an era of personalized medicine, these decisions should be based on the predicted benefit of a treatment on a patient-level. Survival prediction models play a central role as they incorporate the time-to-event and censoring. In medical applications uncertainty is critical especially when treatments differ in their side effect profiles or costs. Additionally, models must be adapted to local populations without diminishing performance and often without the original training data available due to privacy concern. Both points are supported by Bayesian models-yet they are rarely used. The aim of this work is to evaluate Bayesian parametric survival models on public datasets including cardiology, infectious diseases, and oncology. Materials and methods: Bayesian parametric survival models based on the Exponential and Weibull distribution were implemented as a Python package. A linear combination and a neural network were used for predicting the parameters of the distributions. A superiority design was used to assess whether Bayesian models are better than commonly used models such as Cox Proportional Hazards, Random Survival Forest, and Neural Network-based Cox Proportional Hazards. In a secondary analysis, overfitting was compared between these models. An equivalence design was used to assess whether the prediction performance of Bayesian models after model updating using Bayes rule is equivalent to retraining on the full dataset. Results: In this study, we found that Bayesian parametric survival models perform as good as state-of-the art models while requiring less hyperparameters to be tuned and providing a measure of the uncertainty of the predictions. In addition, these models were less prone to overfitting. Furthermore, we show that updating these models using Bayes rule yields equivalent performance compared to models trained on combined original and new datasets. Conclusions: Bayesian parametric survival models are non-inferior to conventional survival models while requiring less hyperparameter tuning, being less prone to overfitting, and allowing model updating using Bayes rule. Further, the Bayesian models provide a measure of the uncertainty on the statistical inference, and, in particular, on the prediction.

Bayesian analysis of Box-Cox transformation model for multi-state progression-free survival data

Copula-based Semiparametric Nonnormal Transformed Linear Model for Survival Data with Dependent Censoring

Bayesian transformation cure frailty models with multivariate failure time data

Dependent Dirichlet Processes for Analysis of a Generalized Shared Frailty Model

[Application of Multi-Stage Competing Risk Model to Survival Data].

Dependent Dirichlet Processes for Analysis of aGeneralized Shared Frailty Model

A discrete approximation method for modeling interval‐censored multistate data

A Multi-parameter regression model for interval censored survival data

Bayesian analyses of multiple random change points in survival models with applications to clinical trials

A General Framework for Survival Analysis and Multi-State Modelling

Semiparametric analysis of transformation models with censored data

Penalized Bayesian forward continuation ratio model with application to high-dimensional data with discrete survival outcomes

Bayesian parametric models for survival prediction in medical applications

A Multi-state Non-Markov Framework to Estimate Progression of Chronic Disease

A Semiparametric Approach for the Nonparametric Transformation Survival Model with Multiple Covariates

Improving Estimation Efficiency of Cox Model via Using Other Related Survival Data

Bayesian transformation model for spatial partly interval-censored data

On semiparametric transformation cure models

Modeling county level breast cancer survival data using a covariate-adjusted frailty proportional hazards model

Inference of Transition Probabilities in Multi-State Models Using Adaptive Inverse Probability Censoring Weighting Technique

Likelihood-Based Inference for Semi-Parametric Transformation Cure Models with Interval Censored Data